Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Process Insights Announces the Acquisition of the Assets of the Process Analyzers Business from Schneider Electric

Process Insights Announces the Acquisition of the Assets of the Process Analyzers Business from Schneider Electric

Process Insights, a Union Park Capital portfolio company, announced today the acquisition of the assets of the Process Analyzers business from Schneider Electric (“Schneider”). Based in Upland, California, Schneider’s process analyzers deliver premium solutions to leading... - June 26, 2022 - Process Insight

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars

GENINVO Launches Its Latest Offering - Innovation as a Service

GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.

Last Mile Delivery Platform FetchGoat Selected for Microsoft for Startups Program

Microsoft for Startups accelerates companies by providing founders the technology, guidance, and support from the idea stage to the exit stage. - June 08, 2022 - FetchGoat

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology

NuvOx Pharma Announces Issuance of a New Patent

NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” - May 19, 2022 - NuvOx Pharma

Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge

Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge

Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually. The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector. - May 13, 2022 - Intrinsica, Inc.

Dr. Pam Gumbs Named VIP Member for 2022 by Strathmore's Who's Who Worldwide Publication

Dr. Pam Gumbs Named VIP Member for 2022 by Strathmore's Who's Who Worldwide Publication

Dr. Pam Gumbs of Berkeley, California has been named as a VIP Member by Strathmore’s Who’s Who Worldwide for 2022 for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the owner and CEO of United Pharmacy... - May 13, 2022 - Strathmore Worldwide

NuvOx Appoints Dr. Robert King to SAB

NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Robert King to its Scientific Advisory Board (SAB). Dr. King is a seasoned life science executive with over 30 years’... - May 11, 2022 - NuvOx Pharma

Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100

Microvascular Therapeutics (MVT), a clinical stage biotechnology company, finalized its manufacturing facility certifications for the GMP production of its first product, MVT-100. - April 21, 2022 - Microvascular Therapeutics

NuvOx Technology Featured in Prominent Peer Review Journal

NuvOx Pharma’s technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, was featured in the prominent journal of Frontiers of Neurology. - April 19, 2022 - NuvOx Pharma

NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials

NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, finalized its manufacturing facility certifications for Phase IIb trials. - April 17, 2022 - NuvOx Pharma

Governor Doug Ducey Signs SB1162 Into Law Helping Arizonans with Chronic Intractable Pain Get the Treatment They Need

Governor Doug Ducey Signs SB1162 Into Law Helping Arizonans with Chronic Intractable Pain Get the Treatment They Need

Senator Nancy Barto introduced Arizona SB1162 in January 2022. This new law will give protections to chronic intractable pain patients in Arizona. This amendment to ARS Section 32-3248.01, will improve access to care, give physicians the ability to treat their patients as medically appropriate, and confirm that providers and their state governing boards have oversight on the proper treatment for these patients. - April 15, 2022 - International Pain Foundation

Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition

Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition

The Web Marketing Association will name the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development. Medial Websites can be entered into consideration for the 2022 Best Medical Website and other medical-related WebAwards at www.webaward.org. - April 10, 2022 - Web Marketing Association

Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100

MicrovMicrovascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Commercialization Readiness Program grant from the National Institute of Heart, Lung, and Blood Institute (NHLBI). Wyatt Unger, MD, MBA, Chief Medical Officer of MVT said, “We are... - April 09, 2022 - Microvascular Therapeutics

FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA

SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks’ time on April 27th and 28th, 2022. - April 08, 2022 - SAE Media Group

Yavari LLC Earns NABP Drug Distributor Accreditation

Yavari LLC has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®). NABP’s Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. Drug... - April 03, 2022 - Yavari LLC

Pipelinepharma Marketplace Records Quadruple Growth Over a Single Year

The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. - April 01, 2022 - Pipelinepharma

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens. - March 31, 2022 - Creative Diagnostics

Myra E. Clements, RPh Recognized as a Professional of the Year for 2022 by Strathmore's Who's Who Worldwide Publication

Myra E. Clements, RPh Recognized as a Professional of the Year for 2022 by Strathmore's Who's Who Worldwide Publication

Myra E. Clements, RPh of Richmond, Virginia, has been recognized as a Professional of the Year for 2022 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievements in the healthcare field. About Myra E. Clements, RPH With over 40 years' experience, Ms. - March 30, 2022 - Strathmore Worldwide

VPL Launches Pharmacy Solution to Ensure Specialty Drugs are Delivered Cost Effectively & Securely

VPL Launches Pharmacy Solution to Ensure Specialty Drugs are Delivered Cost Effectively & Securely

Built on proven technology, VPL provides a single platform for all health systems' supply chain needs. - March 16, 2022 - VPL

PurerVita Ltd. Launches UK First Revolutionary Supplements for Pregnancy and Postpartum Recovery

PurerVita Ltd. Launches UK First Revolutionary Supplements for Pregnancy and Postpartum Recovery

Launch of PurerMama, A positive impact nutritional and wellness brand by doctors at The Baby Show, Excel London. - March 12, 2022 - PurerVita UK Limited

Denver City and County Building Lights Red for Bleeding Disorders Awareness

Denver City and County Building Lights Red for Bleeding Disorders Awareness

The Denver City and County Building located at 1437 Bannock Street was lit in magnificent red lights the week of March 2-7 in honor of Bleeding Disorders Awareness Month (BDAM). With about 3 million people nationwide impacted, it is critical to bring awareness to the important health condition and to advocate for access to diagnosis and ongoing health care. - March 12, 2022 - National Hemophilia Foundation - Colorado Chapter

2022 Women in Oncology Awards

2022 Women in Oncology Awards

The Women in Oncology Awards are presented annually to outstanding women who have made remarkable contributions to the lives of those fighting cancer. The winners of the 2022 Women in Oncology Awards are Karen Kelly, MD, FASCO, Elizabeth A. Mittendorf, MD, PhD, and Rachna T. Shroff, MD, MS. - February 23, 2022 - Cancer Expert Now, Inc.

Cooperative Buying to Help Launch New Medicines in Small Markets

Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world. - February 17, 2022 - Pipelinepharma

Decarbitation Inc. Product Launch: New Cannabis Crude Oil Decarboxylation Technology Using Controlled Cavitation

Decarbitation Inc. Product Launch: New Cannabis Crude Oil Decarboxylation Technology Using Controlled Cavitation

DecarbitationTM will be launching its website as well brand new 2 and 25 gallon systems for the decarboxylation of cannabis on February 2, 2022. - February 01, 2022 - Decarbitation Inc.

‘Dr. Pam’ Gumbs Recognized as a Professional of the Year for 2021 by Strathmore's Who's Who Worldwide Publication

‘Dr. Pam’ Gumbs Recognized as a Professional of the Year for 2021 by Strathmore's Who's Who Worldwide Publication

‘Dr. Pam’ Gumbs of Berkeley, California has been recognized as a Professional of the Year for 2021 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About ‘Dr. Pam’ Gumbs Dr. Pam... - January 25, 2022 - Strathmore Worldwide

BOC Sciences Offers Pharmaceutical Impurities to Assist in Drug Development

BOC Sciences announces the provision of pharmaceutical impurities to assist in drug development. - January 09, 2022 - BOC Sciences

Exclusive Speaker Interview with Karen Capper, AstraZeneca Ahead of the Pharmaceutical Microbiology UK Virtual Conference

SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field. - January 08, 2022 - SAE Media Group

LifeTein Awarded the Fastest Peptide Synthesis Service in 2021

LifeTein Awarded the Fastest Peptide Synthesis Service in 2021

LifeTein was awarded the fastest peptide synthesis service in 2021 by New world Report, thanks to their speedy custom protein, antibody, and chemical services for biotech, pharma, academia, government customers, and diagnostics. Their services reach across the entire United States and more than 30 other nations. LifeTein provides the fastest turnaround time and most reliable quality in the industry, using their proprietary microwave-assisted heating technology for peptide synthesis. - January 07, 2022 - LifeTein

BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification

BOC Sciences recently introduces pharmaceutical impurity identification services to accelerate drug development. - December 30, 2021 - BOC Sciences

‘Dr. Pam’ Gumbs Celebrated as a Woman of Empowerment by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized

‘Dr. Pam’ Gumbs Celebrated as a Woman of Empowerment by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized

‘Dr. Pam’ Gumbs of Berkeley, California has been celebrated as a Woman of Empowerment by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized for her outstanding contributions to the pharmaceutical field for over 40 years. About ‘Dr. Pam’ Gumbs For over 20... - December 22, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only

SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. - December 22, 2021 - SAE Media Group

Pharmaceutical Companies Shift to Near-Shore Medicines Sourcing as Supply Chain Risks Intensify

With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. - December 16, 2021 - Pipelinepharma

IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol

IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol

Nonprofit Seeks Input Into Data Sources and Technical Specifications to Guide Model Development; Will Hold December 15 Webinar to Overview Protocol and Public Comment Process - December 14, 2021 - Innovation and Value Initiative

‘Dr. Pam’ Gumbs to be Showcased in the Winter Issue of P.O.W.E.R. Magazine as a Woman of Distinction

‘Dr. Pam’ Gumbs to be Showcased in the Winter Issue of P.O.W.E.R. Magazine as a Woman of Distinction

‘Dr. Pam’ Gumbs of Berkeley, California will be showcased in the Winter issue of P.O.W.E.R. Magazine as a Woman of Distinction for her outstanding achievements and contributions for over 40 years in the pharmaceutical field. Each quarter, P.O.W.E.R. chooses four exceptional women for... - December 09, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022. - December 09, 2021 - Mirror Biologics, Inc.

PharmStars Announces 2021 Accelerator Graduates

PharmStars Announces 2021 Accelerator Graduates

12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched

Scientific breakthroughs for kidney disease lead to the launch of the first-ever medical food for the daily dietary management of Polycystic Kidney Disease (PKD). - December 06, 2021 - Santa Barbara Nutrients

Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201

Parvus Therapeutics, a biopharmaceutical company developing Navacim™ platform-based disease-specific immunoregulator therapeutics to treat autoimmune diseases by activating endogenous generation of disease-specific regulatory T cells (Tregs) without impairing normal immune system function,... - November 29, 2021 - Parvus Therapeutics U.S., Inc.

7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference

SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK. - November 28, 2021 - SAE Media Group

Navigating the Challenges and Legal Landscapes of Parallel Trade

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. - November 27, 2021 - SAE Media Group

LPA Statement Regarding Voxzogo™

LPA Statement Regarding Voxzogo™

Little People of America (LPA), the world’s oldest and largest support organization for people with dwarfism and their families, has been tracking biotechnical developments for the treatment of individuals with Achondroplasia. LPA President, Mark Povinelli, says, "With the FDA approval... - November 21, 2021 - Little People of America Inc.

Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles

Today Parvus announced it has entered into an agreement with Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO), for process development, scale-up and GMP manufacturing of NavacimTM nanoparticles, a key building block for all of our Navacim platform drug development candidates. - November 19, 2021 - Parvus Therapeutics U.S., Inc.

CANNA/Hemp Extraction Labs USA Announces Joint Venture Partnerships for Cannabis Cultivators/Growers and Cannapreneurs

CANNA/Hemp Extraction Labs USA (CHELUSA) announced today they are offering to finance and commission Cannabis Extraction Labs and Cannabis Cloning Labs in NM, NJ, AZ, IL, MT and VA. CHELUSA is looking to form strategic partnerships with Cultivators/Growers and Cannapreneurs in these key states. The... - November 18, 2021 - Hemp Extraction Labs USA

GENINVO Launches Centre of Excellence for Data Science and Analytics to Help Clients Unlock Insights Using Data Science

GENINVO, a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE). The DSA is a resolute team of experts comprising of life science and technology domains. Data Science and Analytics CoE... - November 18, 2021 - GenInvo, Inc.

Press Releases 1 - 50 of 2,577